MRNA(MRNA)
MRNA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.09B | $2.50B | $3.16B | $5.18B | $6.82B |
| Low | $1.96B | $1.90B | $3.15B | $4.35B | $5.72B |
| High | $2.13B | $4.43B | $3.17B | $7.71B | $10.15B |
| EBITDA Avg | $-498M | $-595M | $-751M | $-1.23B | $-1.62B |
| Low | $-507M | $-1.05B | $-753M | $-1.83B | $-2.41B |
| High | $-466M | $-451M | $-750M | $-1.03B | $-1.36B |
| EBIT Avg | $-549M | $-656M | $-829M | $-1.36B | $-1.79B |
| Low | $-559M | $-1.16B | $-831M | $-2.02B | $-2.66B |
| High | $-514M | $-497M | $-827M | $-1.14B | $-1.50B |
| Net Income Avg | $-3.40B | $-1.84B | $-1.16B | $81M | $1.03B |
| Low | $-3.80B | $-2.39B | $-2.31B | $64M | $816M |
| High | $-2.80B | $-33M | $258M | $133M | $1.69B |
| EPS Avg | $-8.58 | $-4.69 | $-2.82 | $0.21 | $2.66 |
| Low | $-9.76 | $-6.15 | $-5.93 | $0.16 | $2.10 |
| High | $-7.21 | $-0.09 | $0.66 | $0.34 | $4.34 |
| Analysts (Rev / EPS) | 17 / 17 | 17 / 17 | 18 / 17 | 11 / 13 | 9 / 7 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $102M | $913M | $667M | $263M | $116M | $1.17B | $962M |
| Low | $66M | $809M | $557M | $220M | $97M | $974M | $804M |
| High | $177M | $1.07B | $805M | $317M | $140M | $1.41B | $1.16B |
| EBITDA Avg | $-24M | $-217M | $-159M | $-63M | $-28M | $-277M | $-229M |
| Low | $-42M | $-255M | $-191M | $-75M | $-33M | $-334M | $-276M |
| High | $-16M | $-192M | $-133M | $-52M | $-23M | $-232M | $-191M |
| EBIT Avg | $-27M | $-239M | $-175M | $-69M | $-30M | $-306M | $-252M |
| Low | $-46M | $-281M | $-211M | $-83M | $-37M | $-369M | $-304M |
| High | $-17M | $-212M | $-146M | $-58M | $-25M | $-255M | $-211M |
| Net Income Avg | $-813M | $-438M | $-759M | $-717M | $-844M | $-128M | $-376M |
| Low | $-956M | $-709M | $-962M | $-910M | $-1.07B | $-163M | $-477M |
| High | $-537M | $-219M | $-596M | $-564M | $-664M | $-101M | $-296M |
| EPS Avg | $-2.06 | $-1.11 | $-1.92 | $-1.82 | $-2.14 | $-0.33 | $-0.95 |
| Low | $-2.42 | $-1.79 | $-2.44 | $-2.30 | $-2.71 | $-0.41 | $-1.21 |
| High | $-1.36 | $-0.55 | $-1.51 | $-1.43 | $-1.68 | $-0.26 | $-0.75 |
| Analysts (Rev / EPS) | 11 / 12 | 11 / 12 | 5 / 10 | 5 / 5 | 6 / 5 | 9 / 5 | 5 / 5 |